Valuation: ScripsAmerica, Inc.

Market Cap 40.98L 36.43L 33.76L 30.72L 57.97L 39Cr 58.9L 4.06Cr 1.59Cr 20Cr 1.54Cr 1.51Cr 65Cr P/E 2013
-0.76x
P/E 2014 -4.13x
Enterprise Value 52.24L 46.43L 43.04L 39.16L 73.89L 50Cr 75.08L 5.17Cr 2.03Cr 26Cr 1.96Cr 1.92Cr 82Cr EV / Sales 2013
2,37,13,364x
EV / Sales 2014 7,67,004x
Free-Float
97.92%
Yield 2013 *
-
Yield 2014 -
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
Manager TitleAgeSince
Chief Executive Officer - 30/06/2015
Director TitleAgeSince
Chairman - 30/06/2015
Director/Board Member 50 26/03/2015
Director/Board Member 50 19/07/2016
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 141
+2.17%+9.05%-41.13%+0.29% 1.53TCr
+12.10%-4.19%+7.38%-24.67% 714.01Cr
+0.43%+3.43%-12.09%-1.03% 630.26Cr
+1.47%+3.52%-12.42%+6.21% 624Cr
+1.52%+6.94%-51.38%-39.05% 609.76Cr
-3.17%+6.59%+3.89%-10.24% 469.15Cr
+2.67%+15.56%-32.63%-4.76% 343.72Cr
-0.69%+1.36%+8.70%-23.32% 318.86Cr
+0.26%+1.56%-14.59%-6.54% 322.83Cr
Average +1.67%+2.80%-16.03%-11.46% 556.66Cr
Weighted average by Cap. +2.40%+3.62%-20.81%-9.66%

Financials

2013 2014
Net sales 0.56 0.49 0.46 0.42 0.79 52.79 0.8 5.51 2.16 27.55 2.09 2.04 87.81 30.85 27.43 25.42 23.13 43.64 2.93T 44.34 305.57 119.81 1.53T 115.8 113.33 4.87T
Net income -1.12Cr -99.51L -92.24L -83.92L -1.58Cr -106.25Cr -1.61Cr -11Cr -4.35Cr -55Cr -4.2Cr -4.11Cr -176.75Cr -47.31L -42.05L -38.98L -35.46L -66.92L -45Cr -67.99L -4.69Cr -1.84Cr -23Cr -1.78Cr -1.74Cr -75Cr
Net Debt 24.82L 22.06L 20.45L 18.6L 35.1L 24Cr 35.67L 2.46Cr 96.36L 12Cr 93.13L 91.15L 39Cr 11.26L 10.01L 9L 8L 15.92L 11Cr 16.18L 1.11Cr 43.71L 5.57Cr 42.25L 41.35L 18Cr
Logo ScripsAmerica, Inc.
ScripsAmerica, Inc. is engaged in the distribution of prescription and over the counter pharmaceuticals. The Company's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). It also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.
Employees
-
  1. Stock Market
  2. Stocks
  3. SCRCQ Stock